WNT5A
protein-codingWnt family member 5A, the group of Wnt family
Gene summary
The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene encodes a member of the WNT family that signals through both the canonical and non-canonical WNT pathways. This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2. This protein plays an essential role in regulating developmental pathways during embryogenesis. This protein may also play a role in oncogenesis. Mutations in this gene are the cause of autosomal dominant Robinow syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0024455
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008389
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0024455
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008389
Submitter: ClinGen
The WNT5A gene is located on chromosome 3 at 3p14.3 and encodes the Wnt family member 5A protein, which is a ligand for members of the frizzled family of seven transmembrane receptors, and is involved in both the canonical and noncanonical signaling pathways, depending upon the receptor context. WNT proteins play an essential role during development, controlling processes such as embryonic patterning, cell growth, migration, and differentiation. The WNT5A gene was first reported in relation to autosomal dominant Robinow syndrome in 2010 (Person et al., PMID 19918918). Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least eight probands from four publications (Person et al., 2010 PMID 19918918; Roifman et al., 2015 PMID 24716670; Xiong et al., 2016 PMID 27092434; White et al., 2018 PMID 29276006). Variants in this gene segregate with disease in approximately nine family members from three families. As a result of this re-evaluation, five additional variants in six probands (one duplication and four missense variants) reported in four publications (PMIDs: 34627339. 35047859, 35586607, 34750320) have been included in this curation. The mechanism of disease has not been clearly defined, but missense variants were most commonly reported, with functional data for two of the missense variants suggesting they are hypomorphic (Person et al., 2010 PMID 19918918). Of note, there is one report of an autosomal recessive form of Robinow syndrome caused by a homozygous frameshift variant in WNT5A, resulting in perinatal death (Birgmeier et al., 2018 PMID 29575632). This gene-disease relationship is supported by expression data, biochemical function data, a knockout mouse model and a chick embryo limb model expressing a WNT5A variant found in a proband (Yamaguchi et al., 1999 PMID 10021340; Oishi et al., 2003 PMID 12839624; Mikels and Nusse, 2006 PMID 16602827; Gignac et al., 2019 PMID 31032853). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on October 27th, 2020 (SOP Version 8). This GDR was re-evaluated on April 25th, 2024 (SOP Version 10). Although new genetic evidence was published (PMIDs: 34627339. 35047859, 35586607, 34750320), the classification did not change.
Inheritance Pattern: AD
Disease ID:MONDO:0024455
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0024455
Submitter: Illumina
The WNT5A gene is located on chromosome 3 at 3p14.3 and encodes Wnt family member 5A, which is a ligand for members of the frizzled family of seven transmembrane receptors and is involved in both the canonical and noncanonical signaling pathways, depending upon the receptor context. WNT proteins play an essential role during development, controlling processes such as embryonic patterning, cell growth, migration, and differentiation. The WNT5A gene was first reported in relation to autosomal dominant Robinow syndrome in 2010 (19918918: Person et al. 2010). Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least eight probands in four publications (19918918: Person et al. 2010; 24716670: Roifman et al. 2015; 27092434: Xiong et al. 2016; 29276006: White et al. 2018). Variants in this gene segregated with disease in approximately nine additional family members. The mechanism of disease has not been clearly defined, but missense variants were most commonly reported, and functional data for two suggested they were hypomorphic (19918918: Person et al. 2010). This gene-disease relationship is supported by expression and biochemical function data as well as a knock out mouse model (10021340: Yamaguchi et al. 1999; 12839624: Oishi et al. 2003; 16602827: Mikels and Nusse 2006). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged.
Inheritance Pattern: AD
Disease ID:MONDO:0024455
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dental; Genitourinary; Musculoskeletal; Renal
Intervention: Renal
Rationale: Individuals have been described with high-grade vesicoureteral reflux, and surveillance and management may be helpful to preserve renal function
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to WNT5A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003392.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 60 | 2 | 68 | ||
| missense | 3 | 10 | 143 | 18 | 6 | 180 |
| nonsense | 0 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 3 | 4 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 3 | 11 | 155 | 78 | 8 | 255 |
Highest pathogenic variant AF is 7.6715475e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003383.4 | 5 | MANE Select | |
| Ensembl | ENSP00000264634.4 | 5 | MANE Select | |
| RefSeq | NP_001243034.1 | 4 | Standard | |
| RefSeq | NP_001364200.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| wnt5a | Danio rerio | Structure: perichondrium Quality: edematous abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric cancer - Homo sapiens (human)
- mTOR signaling pathway - Homo sapiens (human)
- Cushing,s syndrome - Homo sapiens (human)
- Breast cancer - Homo sapiens (human)
- HTLV-I infection - Homo sapiens (human)
Biological Process
- activation of MAPK activity
- establishment of planar polarity
- somitogenesis
- epithelial to mesenchymal transition
- positive regulation of endothelial cell proliferation
Molecular Function
- DNA-binding transcription factor activity
- frizzled binding
- receptor tyrosine kinase-like orphan receptor binding
- cytokine activity
- protein binding
Cellular Component
- extracellular region
- extracellular space
- endoplasmic reticulum lumen
- Golgi lumen
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000474267
- Coding exons
- 5
- Length
- 24231
- Individuals with no LoFs
- 124736
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124737
- p
- 0.00000401
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.98 | 159 | 246 | 0.645 | 0.0000167 | 2480 |
| Missense (PolyPhen) | 42 | 105.92 | 0.39653 | 962 | ||
| Synonymous | 0.587 | 96 | 104 | 0.927 | 0.00000786 | 716 |
| Loss of Function | 3.67 | 1 | 17.6 | 0.0568 | 9.05e-7 | 189 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors. Can activate or inhibit canonical Wnt signaling, depending on receptor context. In the presence of FZD4, activates beta-catenin signaling. In the presence of ROR2, inhibits the canonical Wnt pathway by promoting beta-catenin degradation through a GSK3-independent pathway which involves down-regulation of beta-catenin-induced reporter gene expression (By similarity). Suppression of the canonical pathway allows chondrogenesis to occur and inhibits tumor formation. Stimulates cell migration. Decreases proliferation, migration, invasiveness and clonogenicity of carcinoma cells and may act as a tumor suppressor (PubMed:15735754). Mediates motility of melanoma cells (PubMed:17426020). Required during embryogenesis for extension of the primary anterior-posterior axis and for outgrowth of limbs and the genital tubercle. Inhibits type II collagen expression in chondrocytes (By similarity). {ECO:0000250|UniProtKB:P22725, ECO:0000250|UniProtKB:Q27Q52, ECO:0000269|PubMed:15735754, ECO:0000269|PubMed:17426020}.;
- Disease
- DISEASE: Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700]: A disease characterized by short-limb dwarfism, costovertebral segmentation defects and abnormalities of the head, face and external genitalia. The clinical signs are generally milder in dominant cases. {ECO:0000269|PubMed:19918918}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.637
Intolerance Scores
- RVIS EVS
- -0.16
- RVIS percentile EVS
- 41.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.986
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |